Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 2012

View Archived Issues

New resource makes genome data and interpretations public

Chinese researchers present novel inhibitors of platelet aggregation

Nerviano Medical Sciences discloses new protein kinase inhibitors

Novartis patents new CDK9/cyclin-T1 inhibitors

Novel B-raf inhibitors divulged by Boehringer Ingelheim

Novel RAR-related orphan receptor-gamma modulators developed

Novel candidate HIV drugs designed by GlaxoSmithKline

Curegenix reports new lysophospholipid LPA1 receptor antagonists

New candidate analgesics synthesized at Eli Lilly

Model allows prediction of bacterial responses to multidrug combinations

New potential stroke therapeutic enters clinic

Ark Therapeutics and EMD Millipore take first collaborative steps for virus vaccines

ReNeuron clear to advance phase I stem cell trial

European study reveals new marker of stroke outcome

Treatment begins in phase I trial of SOR-C13

Biovest holds end-of-phase III meeting for BiovaxID

FDA advisory committee schedules review of lomitapide NDA

Aptalis launches new pancrelipase tablets in U.S.

Fusion protein blocking BMP signaling stimulates bone formation

HSV-2 vaccine enters phase I/IIa study

Sublingual fibromyalgia medication shows promise for chronic use

GMP development of CS-TATI-1 begins

Mologen announces progress in first half of 2012

FDA accepts complete response regarding Ampligen NDA

Natural immunomodulator for Crohn's disease enters new trial

Debio-0932 enters new NSCLC study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...